Last year, DeepMind produced a stunning advance in scientific research, demonstrating how its artificial intelligence could be used to predict 3D structures of unique proteins in a solution to a ...
Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL) Isomorphic Labs says its first artificial-intelligence-designed medicines are nearly ready for human testing. What Happened: Isomorphic Labs President ...
The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable information ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with ...
Alphabet has created a new subsidiary called Isomorphic Labs that will focus on using AI processes to develop new drugs. An offshoot from Deepmind, another AI subsidiary of Alphabet, the idea for ...
The company will build off of breakthroughs in protein prediction from DeepMind and inches Big Tech one step further into the healthcare industry. Reading time 2 minutes Alphabet has spun off a new ...
Roland is a technology enthusiast who loves to tinker and geek out about the latest smartphones, tablets, smartwatches, and other wearables and gadgets. He aims to provide honest reviews and thoughts ...
Last year, DeepMind’s AlphaFold2 AI system made a “significant contribution to humanity’s understanding of biology.” Alphabet has now taken that advancement and created a new company called Isomorphic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback